Doubts Raised About Off-Label Use of Subsys, a Strong Painkiller
Wednesday, May 14, 2014 - 08:00
in Health & Medicine
The drug was approved in 2012 for cancer patients, but has since become an outsize moneymaker for Insys Therapeutics and has been prescribed more widely.